RNA fusions are becoming increasingly important in the diagnosis and treatment of cancer. As such, they now feature in a number of mainstream Next Generation Sequencing assays. Our RNA Fusion product range uses cell lines containing onco-relevant fusions in their genomic DNA to provide the most patient-commutable Reference Standard for the validation of fusion sequencing assays.
|Product Name||Catalog ID||Description||Price||Quantity|
|HD784||The ALK-RET-ROS1 targeted FFPE RNA Fusion Reference Standards are a highly-characterized, biol...||
|HD796||The 5-Fusion Multiplex FFPE RNA Reference Standard is a highly-characterized, biologically-rel...||
|HD783||The 5-Fusion Multiplex (Negative Control) FFPE RNA Reference Standard is a highly-characterize...||